Antagonistic effects of the staphylococcal enterotoxin A mutant, SEAF47A/D227A, on psoriasis in the SCID-hu xenogeneic transplantation model

Journal of Investigative Dermatology

Volumn 116, Issue 4, 2001, Pages 596-601

  Boehncke, Wolf Henning ^a   Hardt Weinelt, Katja ^a   Wolter, Manfred ^a   Ochsendorf, Falk Rüdiger ^a   Kaufmann, Roland ^a   Nilsson, Helen ^b   Dohlsten, Mikael ^c   Antonsson, Per ^b  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b Active Biotech Research AB   (Sweden)

^c Department of Cell and Molecular Biology ^*  (Sweden)

Author keywords

Animal model; Autoimmunity; Skin; T lymphocytes; Therapy

Indexed keywords

BACTERIAL ANTIGEN; EXFOLIATIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUTANT PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SCID MOUSE; T LYMPHOCYTE; TOXIN ANALYSIS; XENOTRANSPLANTATION;

EID: 0035050210     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01295.x     Document Type: Article

References (32)

1. Characterization of two distinct MHC class II binding sites of the superantigen staphylococcal enterotoxin A
2. Superantigens and tolerance
3. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions
4. Psoriasis and bacterial superantigens - Formal or causal correlation?
5. The SCID-hu xenogeneic transplantation model: Complex but telling
6. Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice
7. Pulling the trigger on psoriasis
8. The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugs
9. In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis
10. Induction of elapsing paralysis in experimental allergic encephalomyelitis by bacterial superantigen
11. Genetics of psoriasis: Paternal inheritance and a locus on chromosome 6p
12. Patient subgroups and the inflammatory pattern in psoriasis
13. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology
14. 1α,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice
15. Superantigen-based immunotherapy: A phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer
16. A superantigen - Antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies
17. Genetically engineered superantigens as tolerable antitumor agents
18. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes
19. Atopic dermatitis: Immunobiology and treatment with immune modulators
20. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis
21. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotypes
22. Negative selection of lymphocytes
23. Evidence for the effects of a superantigen in rheumatoid arthritis
24. T cell cytotoxicity assays for studying the functional interaction between the superantigen SEA and TCR
25. Animal models of psoriasis - What can we learn from them?
26. Staphylococcal enterotoxins A, D, and E. Structure and function, incuding mechanism of T-cell superantigenicity
27. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q
28. Psoriasis: A T-cell mediated autoimmune disease induced by streptococcal superantigens?
29. Serial triggering of many T-cell receptors by a few peptide-MHC complexes
30. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease
31. Dermal injection of immunocytes induces psoriasis
32. Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis